Recent advancements in the management of COVID-19 infection

This review offers an extensive summary of the latest progress in understanding and managing COVID-19, a disease affecting multiple systems and caused by SARS-CoV-2. It underscores the growing insights into the virus's pathophysiology, covering infection mechanisms, immune responses, and variant-induced changes that impact disease severity and treatment results. Significant advancements in diagnostics, including RT-qPCR, RT-LAMP, rapid antigen tests, advanced imaging, biomarkers, and genomic surveillance, have greatly enhanced early detection, monitoring, and variant identification. Preventive measures have evolved from non-pharmacological approaches to highly effective first-generation and next-generation vaccines, bolstered by improved public health practices. Therapeutic advancements encompass early antiviral use, targeted immunomodulators such as corticosteroids and IL-6 or JAK inhibitors, monoclonal antibodies, and crucial supportive care involving oxygen therapy, anticoagulation, and organ support. Special groups, including pregnant women, children, the elderly, and immunocompromised individuals, require tailored care due to their unique vulnerabilities. Despite considerable progress, challenges persist, such as variant-driven immune escape, global disparities in healthcare access, safety concerns, and unresolved research gaps regarding long-term immunity and optimal therapeutic strategies. The review stresses the importance of ongoing innovation, enhanced global collaboration, and adaptable clinical frameworks to ensure effective COVID-19 management and preparedness for future pandemics.